Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Li Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1340-5333; OpenAlex author ID A5051921751. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 2 papers

Papers 4

  1. Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer. Co-author DOI 10.1080/14728222.2020.1743681↗
  2. An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness. Co-author DOI 10.3389/fcell.2020.00287↗
  3. Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response. Co-author DOI 10.1158/1078-0432.ccr-19-0799↗
  4. High Glucose-Induced ROS Production Stimulates Proliferation of Pancreatic Cancer via Inactivating the JNK Pathway. Co-author DOI 10.1155/2018/6917206↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel D. Billadeau · 3 shared papers, 2019–2020 · strength 0.41
  2. Jin‐San Zhang · 2 shared papers, 2019–2020 · strength 0.17
  3. Zhenkun Lou · 1 shared paper, 2020 · strength 0.09
  4. Meiyu Quan · 1 shared paper, 2020 · strength 0.09
  5. Jiayu Liu · 1 shared paper, 2020 · strength 0.09
  6. Qiang Guo · 1 shared paper, 2020 · strength 0.09
  7. Xiandong Zhu · 1 shared paper, 2018 · strength 0.08
  8. Jiao Min Luo · 1 shared paper, 2018 · strength 0.08
  9. Fubiao Ni · 1 shared paper, 2018 · strength 0.08
  10. Bicheng Chen · 1 shared paper, 2018 · strength 0.08
  11. Yukai Xiang · 1 shared paper, 2018 · strength 0.08
  12. Mengtao Zhou · 1 shared paper, 2018 · strength 0.08
  13. Vijay Sagar Madamsetty · 1 shared paper, 2019 · strength 0.08
  14. Debabrata Mukhopadhyay · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.